Invenomic Capital Management’s Huckleberry.ai, Inc. Class B Common Stock HUCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-171,853
Closed -$1.33M – 163
2025
Q1
$1.33M Sell
171,853
-48,622
-22% -$389K 0.07% 161
2024
Q4
$1.56M Sell
220,475
-35,580
-14% -$288K 0.07% 151
2024
Q3
$1.92M Sell
256,055
-49,433
-16% -$377K 0.11% 136
2024
Q2
$2.36M Sell
305,488
-11,476
-4% -$85.8K 0.11% 142
2024
Q1
$2.83M Buy
316,964
+93,858
+42% +$975K 0.15% 120
2023
Q4
$2.3M Sell
223,106
-194,544
-47% -$1.8M 0.1% 141
2023
Q3
$4.1M Sell
417,650
-88,641
-18% -$1.23M 0.17% 104
2023
Q2
$7.42M Buy
506,291
+439,612
+659% +$6.49M 0.38% 71
2023
Q1
$946K Buy
+66,679
New +$939K 0.05% 136

Other funds holding HUCK

Invenomic Capital Management's HUCK Position: Q2 2025 in Review

Invenomic Capital Management sold out of Huckleberry.ai, Inc. Class B Common Stock (HUCK) in Q2 2025, closing a stake of 171,853 shares — an estimated $1.33M sold.

Invenomic Capital Management first reported a position in HUCK in Q1 2023 and held it in 9 quarters. The position peaked at $7.42M in Q2 2023. 131 funds tracked by Wall St. Rank hold HUCK as of Q2 2025.

  • Invenomic Capital Management reported no remaining Huckleberry.ai, Inc. Class B Common Stock position as of Q2 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 171,853 Huckleberry.ai, Inc. Class B Common Stock shares in Q2 2025, an estimated $1.33M.
  • Invenomic Capital Management first reported a position in Huckleberry.ai, Inc. Class B Common Stock in Q1 2023 and held it in 9 quarters.
  • Invenomic Capital Management's Huckleberry.ai, Inc. Class B Common Stock position peaked at $7.42M in Q2 2023.
  • 131 funds tracked by Wall St. Rank held Huckleberry.ai, Inc. Class B Common Stock as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.